Another plus measure for which evidence is increasing is nasal decolonization for patients who are colonized with methicillin-resistant Staphylococcus aureus (MRSA) and also sensitive strains. Most studies to date have been performed using mupirocin, an antibiotic ointment.21,22 Concerns regarding antibiotic resistance, patient compliance, and cost have prompted the introduction of alternative products (for nasal decolonization), such as antiseptics (eg, povidone iodine and isopropyl alcohol), which are less expensive than anti- biotics and are designed to be applied by perioperative personnel one hour before surgery instead of by the patient for several days before the procedure.23-26 New product introduction is an area in which IPs can assist perioperative personnel by sharing product information and associated evidence for its use. This can facilitate an informed decision by the perioperative team regarding whether or when to expand an existing SSI prevention program to target pro- cedures that prevent SSIs.